CN Stock MarketDetailed Quotes

R&G PharmaStudies (301333)

Watchlist
  • 69.43
  • +0.96+1.40%
Noon Break Apr 15 11:30 CST
6.71BMarket Cap49.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

R&G PharmaStudies (301333) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
临床试验相关及实验室服务438.27M51.50%
Clinical trial technical service412.74M48.50%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
研究和试验发展851.01M100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Territory779.64M91.61%
Overseas71.37M8.39%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +0.09%
Sample Name
Sample Code
 -5.17%
Sample Name
Sample Code
 -5.38%
4
SHANGHAI PECHEM
00338
-9.15%
5
CNOOC
00883
-12.50%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +24.39%
Sample Name
Sample Code
 +16.79%
Sample Name
Sample Code
 +15.71%
4
Hangzhou Shunwang Technology
300113
+12.14%
5
Ucloud Technology Co., Ltd
688158
+10.22%
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -